Effect of Compression Force and Concentration of Superdisintigrant on Directly Compressed Tablets of Metformin HCl

DOI:

https://doi.org/10.37285/ijpsn.2014.7.4.10

Authors

  • Suryakanta Swain
  • Chinam Niranjan Patra
  • Kahnu Charan Panigrahi
  • Muddana Eswara Bhanoji Rao
  • Rashmita Patro

Abstract

The present research work was to evaluate the effect of compression force and concentration of superdisintigrant on tableting properties of metformin HCl. Initially powder mixtures of drug, croscarmellose sodium (0.62% to 10% w/w) and microcrystalline cellulose PH-200 sufficient quantity were prepared and evaluate their pre-compression parameters of different formulation batches such as angle of repose, bulk density, tapped density, Hausner’s ratio and compressibility index. The prepared powder mixtures of different batches were compressed into tablet using hydraulic pellet press machine at two optimized compression forces (77 MPa and 154 MPa). The post compression parameters such as thickness, diameter, weight variation, hardness, friability, drug content, disintegration time and in-vitro drug release study of the prepared tablets were evaluated. FT-IR and DSC studies showed that no incompatibility of the selected drug with the selected excipients. At selected compression force (77 MPa) and increased concentration of superdisintigration (0.62% to 10% w/w) of formulations F1 to F5 indicated that, disintegration time were periodically decreased up to F3 (1.25% w/w croscarmellose sodium). When the concen-tration of superdisintigrant increased up to 10% showed that disintegration time were periodically increased. Similarly, at compression force 154 MPa there is increased in tablet hardness but this effect was less significant when the superdisintegrant concentration more than 1.25% w/w. The hardness and drug content of all the formulations were found to be 3.59 ± 0.23 to 4.85 ± 0.01 kg/cm2 and 97.89 ± 0.10% to 99.42 ± 0.03% respectively. The in-vitro drug release data suggested that drug release of all the formulations followed Higuchi’s kinetic (R> = 0.998). The release rate exponent values (n) suggested the mechanism of drug release followed Quasi-Fickian diffusion mechanism at compression force 77 MPa and anomalous diffusion mechanism at compression force 154 MPa, respectively.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Metformin HCl, Compression force, Croscarmellose sodium, Disintegration time, in-vitro drug release

Downloads

Published

2014-11-30

How to Cite

1.
Swain S, Patra CN, Panigrahi KC, Rao MEB, Patro R. Effect of Compression Force and Concentration of Superdisintigrant on Directly Compressed Tablets of Metformin HCl. Scopus Indexed [Internet]. 2014 Nov. 30 [cited 2024 Jul. 6];7(4):2677-84. Available from: http://ijpsnonline.com/index.php/ijpsn/article/view/755

Issue

Section

Research Articles

References

Jivaldo RM (2003). Thermal analysis of the antiretroviral zidovudine (AZT) and evaluation of the compatibility with excipients used in solid dosage forms. Int J Pharm 260(2): 303-314.

Anderson NR and Banker GS (1989). Pharmaceutical Dosage Forms: Tablets (Edited by Herbert Lieberman, Leon Lachman and Joseph B. Schwartz), Volume 1, Second Edition, CRC Press: 314-24.

Banker GS and Anderson NR (1986). Tablets. In: Theory and Pactice of Industrial Pharmacy (Lachman L, Lieberman H.A, Kaniz J.L. Editors.). Varghese Publishing House, Bombay: 293-342.

Bogda MJ (2002). Tablet compression - Machine theory, design and process troubleshooting. In: Encyclopaedia of Pharmaceutical Technology. Marcel Dekker Inc, New York: 2669-74.

Boldhane SP and Kuchekar BS (2009). Gastroretentive drug delivery of metformin hydrochloride: formulation and in vitro evaluation using 32 full factorial design. Current Drug Deliv 6(5): 477-485.

Ching-Ling C, Lawrence X, Hwei-Ling L, Chyun Yu Y, Chang Sha, L and Chen Hs C (2004). Biowaiver extension potential to BCS Class-III high solubility-low permeability drugs: bridging evidence for metformin immediate-release tablet. Eur J Pharm Sci 22(4): 297-304.

Giovanna C, Gaetano C, Francesca M, Marzia and Paola M (2007). Physical-chemical characterization of binary systems of metformin hydrochloride with triacetyl-β-cyclodextrin. J. Pharm. Biomed Analysis 45(3): 480-486.

Gohe MC and Jogani PD (2003). Exploration of melt granulation technique for the development of co-processed directly compressible adjuvant containing lactose and microcrystalline cellulose. Pharm Dev Technol 8(2):175-85.

Gouldson MP and Deasy PB (1997). Use of cellulose ether containing excipients with microcrystalline cellulose for the production of pellets containing metformin hydrochloride by the process of extrusion-spheronization. J Microencapsul 14(2):137-53.

Huc LD, Liu Y, Tang X and Zhang Q (2006). Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets. Eur J Pharm Biopharm 64(2):185-92.

Jammula S, Patra CN, Swain S, Panigrahi KC, Nayak S, Dinda SC and Rao MEB (2014). Design and characterization of cefuroxime axetil biphasic floating minitablets. Drug Delivery Early Online: 1-11, DOI: 10.3109/10717544.2013.871603.

Kamlesh JW, Rajendra BK and Milind JU (2011). Formulation of sustained release metformin hydrochloride matrix tablets: influence of hydrophilic polymers on the release rate and in vitro evaluation. Int. J. Res. Controlled Rel 1(1): 9-16.

Khar R (2004). Taste masking technologies in oral pharmaceuticals: Recent development and approaches. Drug Dev Ind Pharm 30: 429-48.

Lindberg N, Palsson M, Pihl A, Freeman R, Freeman T, Zetzener H and Enstad G (2004). Flowability measurements of pharmaceutical powder mixtures with poor flow using five different techniques. Drug Dev. Ind Pharm 30(7): 785-791.

Mohapatra A, Parikh RK and Gohel MC (2008). Formulation, development and evaluation of patient friendly dosage forms of metformin, Part-III: Soluble effervescent tablets. Asi J. Pharm. 2(3): 177-181.

Nagar P, Singh K, Chauhan I, Verma M and Yasir M (2011). Orally disintegrating tablets: Formulation, preparation techniques and evaluation. J Appl Pharm Sci 1(4): 35-45.

Parrot EL (1990). Compression In: Pharmaceutical dosage forms- Tablets (Lieberman HA, Lachman L and Schwartz J.B). Marcel Dekker Inc: New York, 153-82,

Patel A, Ray S and Thakur RS (2006). In vitro evaluation and optimization of controlled release floating drug delivery system of metformin hydrochloride. DARU J Pharm Sci 14(2): 57-64.

Patil M, Kakade SM and Pathade SG (2011). Formulation and evaluation of orally disintegrating tablet containing tramadol HCl by mass extrusion technique. J Appl Pharm Sci 1(6): 178-81.

Prajapati ST, Patel PB and Patel CN (2012). Formulation and evaluation of sublingual tablets containing sumatriptan succinate. Int J Pharm Investig 2(3):162-168.

Roy A, Roy K, Roy S, Ghosh A, Ali KA and Deb J (2012). Response surface optimization of sustained release metformin-hydrochloride matrix tablets: influence of some hydrophilic polymers on the release. Int. Sch. Res. Net 2: 1-10.

Rubnic EM, Schwartz JD (2001). Oral solid dosage forms. In: The Science and Practice of Pharmacy (Remington). 20th ed. Lippincott Williams and Wilkins: 859-71.

Scott L, Childs LJC, Jeanette TD, David AC, Barbara CSG and Patrick S (2004). A metastable polymorph of metformin hydrochloride: isolation and characterization using capillary crystallization and thermal microscopy techniques. Crystal Growth Des 4(3): 441-449.

Sweetman CM (2002). The Complete Drug Reference. 33rd ed., London: The Pharmaceutical Press: 332.

Umapathi PJ and Ayyappan SD (2012). Quantitative determination of metformin hydrochloride in tablet formulation containing croscarmellose sodium as superdisintegrant by hplc and uv spectrophotometry. Trop J Pharm Res 11(1): 107-116.